CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 

Celgene Corp  (CELG)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Celgene Corp

CELG's Financial Statements and Analysis



       
 
Celgene Corp reported in III. Quarter net earnings per share of $0.21 an improvement compare to net loss per share of $-0.04 recorded a year ago and decline of 0 % from $0.75 earned in II. Quarter (Jun 30 2016).

More on CELG's Income Statement

   
     

       
 
III. Quarter
Earnings Per Share Revenues
$ 0.21 $  2,983 Mill
$+0.25     $+649M     +27.79 %
   
     
       
     
     

       
  Celgene's Revenue rose by 27.79 % in III. Quarter (Sep 30 2016) year on year, to $2,983 million and advanced by 8.3 % sequentially.

More on CELG's Growth

   
     

Celgene is Expected to report next financial results on January 23, 2017.

       
  • REVLIMID 11.81% Y/Y,
• ABRAXANE 8.34% Y/Y,
• Other 350% Y/Y,
• Total product sales 18.18% Y/Y,
• ISTODAX 10.19% Y/Y,
• POMALYST, IMNOVID 41.63% Y/Y,
• azacitidine injection 7.04% Y/Y
   
     
       
  • THALOMID -13.1% Y/Y,
• VIDAZA -6.46% Y/Y
   
     


  • CELG's Segments
       
 
You need to upgrade your Flash Player


More on CELG's EPS
   
     
       
  CELG's NET INCOME
Celgene's net income of $171 million in III. Quarter increased from net loss of $-34 million III. Quarter a year ago.

Sequentially net earnings fell by -71.35 % from net income of $598.20 million realized in previous quarter.

More on CELG's Growth
   
     

Inventories CELG's Cash flow
Inventories grew by 20.67 % to $508 million from III. Quarter a year ago, sequentially inventories rose by 3.57 %.

More on CELG's Balance Sheets
In III. Quarter company's net cash flow was $459 million, capital expenditures fell by 396.97%, to $-67 millions compare to same quarter a year ago and fell by 52.17% from II. Quarter (Jun 30 2016).

More on CELG's Cash flow Statement
       
 
Celgene Corp does not pay out common stock dividend.

In trailing twelve-month period Celgene Corp earned $ 4.29 cash per share, on a free-cash flow basis 160.17 % of net earning per share.

Book value grew by 1.83 % sequentially to $7.05 per share, 9.52% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ -12.12 per share from $ -12.37.

Company repurchased 0.00 million shares or 0.00 % in III. Quarter.
Interest Coverage Ratio was 2.59. Debt Coverage Ratio was 0.09.

More on CELG's Dividends

   
     
       
 
 Market Capitalization (Millions $) 91,066
 Shares Outstanding (Millions) 802
 Total Debt (Millions $) 14,304
 Revenue (TTM) (Millions $) 10,812
 Net Income (TTM) (Millions $) 2,131
 Cash Flow (TTM) (Millions $) -494
 Capital Exp. (TTM) (Millions $) -311
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,012
   
     
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
BNBI's Profile
Stock Price
BNBI's Financials
BNBI's Expectations
Business Description
Fundamentals
Charts & Quotes
BNBI's News
Suppliers
BNBI's Competitors
Customers & Markets
Economic Indicators
BNBI's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com